Skip to main content

FDA Approvals

FDA Approvals
Anti–PD-1 Antibodies for NSCLC and Renal Carcinoma
Caroline Helwick
Read More
FDA Approvals
Enthusiasm Sky High for Immunotherapy with Anti–PD-1 Agents in Cancer
Caroline Helwick
Read More
FDA Approvals
2014 Oncology Pipeline Looks Impressive
Caroline Helwick, Wayne Kuznar
Read More
FDA Approvals
Gazyva for Chronic Lymphocytic Leukemia: First FDA-Approved Breakthrough Therapy in Oncology
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Adverse Events Reporting in Oncology Studies Suboptimal
Read More
FDA Approvals
Ibrutinib Approved for Chronic Lymphocytic Leukemia
Read More
FDA Approvals
Tafinlar Receives Breakthrough Therapy Designation for Lung Cancer
Read More
FDA Approvals
Brintellix (Vortioxetine) Receives FDA Approval for the Treatment of Major Depressive Disorder
Loretta Fala
Read More
FDA Approvals
Injectafer (Ferric Carboxymaltose Injection) Receives FDA Approval for the Treatment of Iron-Deficiency Anemia
Loretta Fala
Read More
FDA Approvals
Fetzima Extended-Release Receives FDA Approval for the Treatment of Major Depressive Disorder in Adults
Loretta Fala
Read More
Page 45 of 53
Results 441 - 450 of 525